Health Canada2 Apr 2026
Dimension® Creatinine (CRE2)
Health Canada published a recall notice for Dimension® Creatinine (CRE2) on 2 Apr 2026. It is one of 311 notices of this kind from Health Canada since 2 Apr 2026 in AreaZine's record.
Recall
The recall notice
- Issued by
- Health Canada
- Issued
- 2 Apr 2026
- Recall type
- Health product recall
- Companies
- Siemens Healthcare Diagnostics Inc. · 500 Gbc Drive, Newark, Delaware, United States, 19714
- Official source
- Health Canada: the notice at its source
The latest from Health CanadaEvery warning and recall in Canada
Source: Health Canada: the notice at its source. AreaZine rebuilds this page from the agency's record; the agency's page is the one to act on. Contains information licensed under the Open Government Licence – Canada.
The notice as issued
Issue: Siemens Healthineers has confirmed, through investigation of customer complaints, a potential for imprecision in Dimension® Creatinine (CRE2) quality control (QC) and patient sample results when using lot numbers GA6307 and BA7005 on the dimension system. Additional information Details Original published date: 2026-04-02 Affected products: Affected products Lot or serial number Model or catalogue number Dimension® Creatinine (CRE2) GA6307 10872079 Dimension® Creatinine (CRE2) BA7005 10872079 Issue
Source: Health Canada: the notice at its source. The text is the agency's, unedited. Contains information licensed under the Open Government Licence – Canada.